ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JEFFREY HOLVERSON MD

Internal Medicine

1,840

$176K

50
11 are 65+

78%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 11%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 23%

$96
Average prescription price

Avg: $62

LUCINDA BATEMAN MD

Internal Medicine

2,099

$175K

103
32 are 65+

43%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $62

ANDREW COLES M.D.

Internal Medicine

1,001

$75.8K

100
41 are 65+

38%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $62

ROBERT BOURNE MD

Internal Medicine

224

$3,196

105
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 23%

$14
Average prescription price

Avg: $62

MARK JOHNSON MD

Internal Medicine

2,917

$231K

154
121 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $62

PAUL PILGRAM M.D.

Internal Medicine

2,642

$240K

95
64 are 65+

29%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$91
Average prescription price

Avg: $62

HUGH STONEBURNER

Internal Medicine

13,855

$754K

457
290 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

THOMAS KOTTARATHIL

Internal Medicine

16,558

$916K

706
413 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $62

DANIEL MONAHAN M.D.

Internal Medicine

5,273

$353K

192
159 are 65+

22%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $62

LYNN BEARD M.D.

Internal Medicine

16,732

$937K

680
574 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $62

ELENA GONCHAROVA MD

Internal Medicine

2,106

$195K

98
78 are 65+

26%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $62

LESLIE LENERT M.D.

Internal Medicine

491

$21.1K

37
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $62

PENNY PEACOCK M.D.

Internal Medicine

1,186

$109K

64
48 are 65+

23%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$92
Average prescription price

Avg: $62

MATTHEW HANSEN M.D.

Internal Medicine

7,726

$548K

297
262 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $62

JOHN MCCORMICK M.D.

Internal Medicine

1,846

$290K

319
224 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$157
Average prescription price

Avg: $62

ALEXANDER DEL CASTILLO MD

Internal Medicine

9,689

$366K

591
565 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $62

BRANDON ALLEN MD

Internal Medicine

2,286

$119K

166
116 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $62

BRETT WALLIN M.D

Internal Medicine

3,460

$163K

210
129 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $62

YUN LING MD

Internal Medicine

8,022

$409K

518
428 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

R TAYLOR MD

Internal Medicine

6,938

$359K

410
355 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $62

NITA WEBER DO

Internal Medicine

8,673

$445K

329
258 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

GARRY MILLER D.O.

Internal Medicine

7,967

$464K

449
390 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

KEITH LANE MD

Internal Medicine

10,792

$552K

405
379 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

ZANETA BULAJ M.D.

Internal Medicine

7,175

$350K

366
298 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $62

BRUCE BURTENSHAW MD

Internal Medicine

12,803

$611K

482
423 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank